Technologies Available for Licensing
CR-2 BINDING PEPTIDE P28 AS MOLECULAR ADJUVANT FOR DNA VACCINES
The invention is an DNA vaccine and method of use thereof for modulating the immune response against the circumsporozoite protein (CSP) of malaria parasites, using the CR2 binding motifs of C3d, especially p28.
More Detail:Visit USPTO.GOV
Inventor(s):BERGMANN-LEITNER, E.; ANGOV, E.; TSOKOS, G.